Omixon and World Fusion Extend Their Partnership in Japan

World Fusion is a leading bioinformatics company in Japan that focuses on therapeutic target discovery, gene expression analysis, and variant analysis. Their highly skilled and motivated team has been the successful marketer of Omixon’s software products since 2014, and we are pleased to announce World Fusion as a distributor of Omixon’s HLA Genotyping Assay Kits as well.

”We have been thrilled working alongside World Fusion in the last couple years. Their commitment and dedication to provide an excellent service makes them a valued partner of Omixon in Japan. With a common goal to adapt NGS for HLA typing, we are very much looking forward to a successful collaboration in the country” said Nora Nagy, Market Development Manager at Omixon.
We are committed to improve outcomes for transplant patients also in Japan, and believe the transplatation community will benefit from Omixon’s extended partnership with World Fusion.